Latest Articles
- A 45-year-old woman with acute-onset weakness in the intensive care unit
What is the cause of this patient’s symptoms? A self-test.
Sepsis: Menu of new approaches replaces one therapy for allRecombinant human activated protein C is the first therapy approved for treating sepsis. However, instead of a “one therapy for all” approach, we are finding that therapy must be targeted.
- Caring for patients with prosthetic heart valves
General internists have a leading role in providing routine care, including regular physical examinations, echocardiograms, antithrombotic therapy, and antibiotic prophylaxis against endocarditis.
- A 62-year-old man with an abnormal electrocardiogram
Questions and answers on the visible signs of diseases.
- Biological and chemical terrorism: Recognition and management
Future terrorist attacks might involve a variety of chemical or biological agents, including nerve agents, blistering agents, hydrogen cyanide, ricin, anthrax, smallpox, plague, and botulinum toxin. Physicians are on the front line.
When should central venous catheters be changed in the intensive care unit? Should there be a rigid time-based protocol for doing so?The decision is made case by case rather than on a time-based protocol. Proactive strategies can reduce the risk of infection.
- Bioterrorism: An unintended boost to public health?
If anything good comes of recent events, it might be rejuvination of America’s public health system, which has languished in recent years.
- GP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell us
Recent trials addressed whether there are clinical differences among these drugs, whether their empiric use is justified in acute coronary syndromes, and whether they might allow for early invasive management in acute coronary syndromes.